Drug · DIN 02229420
MS CONTIN TABLETS
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 27, 2017.
- Drug Identification Number (DIN)
- 02229420
- Company (DIN owner)
- Purdue PharmaToronto, Ontario, Canada
- Schedule
- Narcotics (cdsa i)
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Morphine N02AA01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MORPHINE SULFATE | 5 MG | TAB |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 6, 1997: NOC 3963Supplement to a New Drug Submission (SNDS) · New strength - 5mg tablets